On October 15, 2010, the Department of Defense (“DoD”) issued a final rule implementing Section 703 of the National Defense Authorization Act (“NDAA”). In this rule DoD takes the position that the NDAA requires pharmaceutical manufacturers to provide discounted drug prices based on the Veterans Health Care Act’s (“VHCA’s”) Federal Ceiling Price (“FCP”), for covered drugs sold by retail pharmacies to TRICARE beneficiaries on or after Jan. 28, 2008 (the date of enactment of the NDAA).
If you are concerned about how this may affect the TRICARE Healthcare Program and Federal Supply Schedules, we invite you to join the government programs experts at Compliance Implementation Services (CIS) for the following complimentary webinar. The speakers, including Reed Smith partner Lorraine M. Campos, will provide information on the following topics:
- TRICARE Final Rule for the inclusion of the TRICARE Retail Pharmacy Program in the Federal Procurement of Pharmaceuticals
- Integrating TRRx utilization in the FCP calculation
DATE: Thursday, October 21st, 2010
TIME: 2:00 – 3:15 PM EDT
